Skip to main content

October 1, 2018

Cancer Moonshot Update: Funding Opportunity Update

The 21st Century Cures Act was signed into law in Dec. 2016 and authorizes $1.8 billion over 7 years to fund the Beau Biden Cancer Moonshot. In response to recommendations provided in the Blue-Ribbon Panel report, the National Cancer Institute has established implementation teams to consider multiple ways to fund Cancer Moonshot-related research. The teams have identified nine upcoming scientific opportunities that directly address the goals of the Cancer Moonshot: Immuno-Oncology Translational Network (IOTN), Pediatric Immunotherapy Discovery and Development Network (PI-DDN), Mechanisms of Cancer Drug Resistance and Sensitivity Network Coordinating Center, Collaborative Research Network for Fusion Oncoproteins in Childhood Cancers, Common Terminology Criteria for Adverse Events (CTCAE) and Patient Reported Outcomes-CTCAE (PRO-CTCAE), Improving Management of Symptoms Across Cancer Treatments (IMPACT), Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes, Accelerating Colorectal Cancer Screening and Follow-Up Through Implementation Science (ACCSIS), and Human Tumor Atlas (HTA) Network.

April 17, 2018

Laura and John Arnold Foundation: Moving the Needle Initiative on Major US Social Problems

[The UNC Office of Corporate and Foundation Relations has identified the following private funding opportunity. Please contact Kavita Hall, or 919-962-2013, for assistance.] The Laura and John Arnold Foundation’s Moving the Needle initiative seeks to encourage state or local jurisdictions, or other entities, to adopt social programs shown in well-conducted randomized controlled trials (RCTs) …

April 17, 2018

NCI Center to Reduce Cancer Health Disparities Career Development Awards to Promote Diversity

The NCI Center to Reduce Cancer Health Disparities is sponsoring Career Development Awards to Promote Diversity. These awards provide funding and three to five years of protected time to support underrepresented individuals in intensive, mentored and non-mentored, cancer-related biomedical, behavioral, or clinical research career development experiences. The awards include NCI Mentored Research Scientist Development Award to Promote Diversity (K01); NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08); NCI Transition Career Development Award to Promote Diversity (K22). More information is available on the Continuing Umbrella of Research Experiences (CURE) page.